We use cookies to improve your experience. By continuing to browse this site, you accept our cookie policy.×
Published Online:https://doi.org/10.4155/bio-2020-0207

Aim: In bioanalytical assays, analyte response is normalized to an internal standard response. When the internal standard works well, it compensates for processing and detection variability. However, in case the internal standard introduces additional variability, due to addition errors or other issues, scientists need to identify this. Results: A new method, using a Q-test for outliers and a t-test to compare internal standard response from different sample types, is applied to 15 cases. The results show that the Q-test/t-test, which uses confidence level rather than arbitrary cut-points, is more discerning of deviations compared with widely used methods. Conclusion: This work may improve the quality of and rationale for the internal standard response monitoring method.

Papers of special note have been highlighted as: • of interest

References

  • 1. Tan A, Awaiye K. Use of Internal Standards in LC–MS Bioanalysis. In: Handbook of LC–MS Bioanalysis: Best Practices, Experimental Protocols and Regulations Li WZhang JTse F (Eds). John Wiley & Sons, NJ, USA, 217–227 (2013).
  • 2. Tan A, Hussain S, Musuku A, Masse R. Internal standard response variations during incurred sample analysis by LC–MS/MS: case by case trouble-shooting. J. Chromatogr. B Analyt. Technol. Biomed. Life Sci. 877(27), 3201–3209 (2009).
  • 3. Merbel NCVD, Koster RA, Ohnmacht C. Very complex internal standard response variation in LC–MS/MS bioanalysis: root cause analysis and impact assessment. Bioanalysis 11(18), 1693–1700 (2019).
  • 4. Buonarati MH, Schoener D. Investigations beyond standard operating procedure on internal standard response. Bioanalysis 11(18), 1669–1678 (2019).
  • 5. Woolf EJ. Learning how to interpret ‘dangerous’ internal standard behaviors. Bioanalysis 11(18), 1679–1684 (2019).
  • 6. Blaye OL. Variations in internal standard response: some thoughts and real-life cases. Bioanalysis 11(18), 1715–1725 (2019).
  • 7. EMA. Guideline on Bioanalytical Method Validation (2011). https://www.ema.europa.eu/en/documents/scientific-guideline/guideline-bioanalytical-method-validation_en.pdf
  • 8. US FDA. Guidance for Industry: Bioanalytical Method Validation (2018). https://www.fda.gov/media/70858/download
  • 9. White S, Adcock N, Elbast W et al. European Bioanalysis Forum: recommendation for dealing with internal standard variability. Bioanalysis 6(20), 2767–2774 (2014). • Describes the ‘rule of thumb’ as a way to systematically address different types of internal standard variabiltiy.
  • 10. US FDA. Evaluation of Internal Standard Responses During Chromatographic Bioanalysis: Questions and Answers (2019). https://www.fda.gov/media/130451/download
  • 11. Fu Y, Barkley D, Li W, Picard F, Flarakos J. Evaluation, identification and impact assessment of abnormal internal standard response variability in regulated LC−MS bioanalysis. Bioanalysis 12(8), 545–559 (2020).
  • 12. Lowes S, Jersey J, Shoup R et al. Recommendations on: internal standard criteria, stability, incurred sample reanalysis and recent 483s by the Global CRO Council for Bioanalysis. Bioanalysis 3(12), 1323–1332 (2011).
  • 13. Harris D. Quantitative Analytical Chemistry. WH Freeman, NY, USA (2006).
  • 14. Rorabacher DB. Statistical treatment for rejection of deviant values: critical values of Dixon's “Q” parameter and related subrange ratios at the 95% confidence level. Anal. Chem. 63(2), 139–146 (1991).